Very early researchStudy completedNCT05093517
What this trial is testing
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
Who this might be right for
Type 2 DiabetesGlucose Tolerance ImpairedInsulin Sensitivity
The University of Texas Health Science Center at San Antonio 4